Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Paracetamol
- Therapeutic area
- Pain & musculoskeletal
- Drug class
- Analgesics / NSAIDs
- ATC
- N02
- Strength
- 500 mg
- Dosage form
- Tablet
- Pack
- 100
- Registration no.
- 061957
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-10 03:32
Manufacturer
Mediate Pharmaceutical Pvt Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Para-Caffine 500 mg tablet
Para-Caffine 500 mg tablet contains Paracetamol 500 mg. It is registered with DRAP by Mediate Pharmaceutical Pvt Ltd (registration no. 061957). Its official price is PKR 207.80 for a pack of 100, about PKR 2.08 per tablet. This price has applied since 27 January 2026. 88 other brands of Paracetamol 500 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other brands of Paracetamol 500 mg
Official price over time
No change in the official DRAP price is recorded for this pack (100). Current price PKR 207.80, effective 27 Jan 2026.
Cite this price history
MedInfoBase. Para-Caffine 500 mg, 100: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/para-caffine-500-mg-061957-100-mediate-pharmaceutical-pvt-ltd/ (accessed 10 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 207.80 | 2026-01-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 061957Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
